Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tecnimede Soc Tecnico-Medicinal S AfiledCriticalTecnimede Soc Tecnico-Medicinal S A
Priority to PE2016002196ApriorityCriticalpatent/PE20170130A1/en
Publication of PE20170130A1publicationCriticalpatent/PE20170130A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion se refiere a un enantiomero (S)-pirlindol o una sal farmaceuticamente aceptable del mismo para su utilizacion en el tratamiento terapeutico o en la prevencion del dolor. Tambien se refiere a una composicion farmaceutica. Dicho compuesto es util en el tratamiento del dolor de tipo neuropaticoThe present invention relates to an (S) -pirlindole enantiomer or a pharmaceutically acceptable salt thereof for use in the therapeutic treatment or in the prevention of pain. It also refers to a pharmaceutical composition. This compound is useful in the treatment of neuropathic pain.
PE2016002196A2014-05-092014-05-09
(S) - PIRLINDOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR USE IN MEDICINE
PE20170130A1
(en)
Use of r-2-4-2-ethoxy-3-4-trifluoromethylphenoxypropyl-thio-2-methylphenoxy acetic acid or a salt thereof in the manufacture of a medicament to treat a condition that is a non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.